Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
We previously showed that macrophages from macrophage-specific ATP-binding cassette transporter A1 (ABCA1) knockout (Abca1(-M/-M)) mice had an enhanced proinflammatory response to the Toll-like receptor (TLR) 4 agonist, lipopolysaccharide (LPS), compared with wild-type (WT) mice. In the present study, we demonstrate a direct association between free cholesterol (FC), lipid raft content, and hyper-responsiveness of macrophages to LPS in WT mice. Abca1(-M/-M) macrophages were also hyper-responsive to specific agonists to TLR2, TLR7, and TLR9, but not TLR3, compared with WT macrophages. We hypothesized that ABCA1 regulates macrophage responsiveness to TLR agonists by modulation of lipid raft cholesterol and TLR mobilization to lipid rafts. We demonstrated that Abca1(-M/-M) vs. WT macrophages contained 23% more FC in isolated lipid rafts. Further, mass spectrometric analysis suggested raft phospholipid composition was unchanged. Although cell surface expression of TLR4 was similar between Abca1(-M/-M) and WT macrophages, significantly more TLR4 was distributed in membrane lipid rafts in Abca1(-M/-M) macrophages. Abca1(-M/-M) macrophages also exhibited increased trafficking of the predominantly intracellular TLR9 into lipid rafts in response to TLR9-specific agonist (CpG). Collectively, our data suggest that macrophage ABCA1 dampens inflammation by reducing MyD88-dependent TLRs trafficking to lipid rafts by selective reduction of FC content in lipid rafts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Direct LXR target genes are ATP binding cassette subfamily A member-1 (ABCA-1) which maintains reverse cholesterol transport and inhibits TLR-2, -4 and -9, NF-κB as well as mitogen-activated protein kinases (MAPK) signaling in macrophages.[161,162]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Cited by
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 876
Assembly and localization of Toll-like receptor signalling complexes
Gay, N. J., Symmons, M. F., Gangloff, M., & Bryant, C. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3713 · Cited by 832
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Płóciennikowska, A., Hromada-Judycka, A., Borzęcka, K., & Kwiatkowska, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1762-5 · Cited by 761
“On the other hand, a deficiency of ATP-binding cassette transporters A1 or G1, linked with cholesterol elevation and an apparent increase of raft content in macrophages, enhanced the partition of TLR4 to raft fractions and augmented proinflammatory signaling [78–80].”
BackgroundMonocyte and Macrophage Dynamics During Atherogenesis
Ley, K., Miller, Y. I., & Hedrick, C. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.221127 · Cited by 554
Regulation of macrophage immunometabolism in atherosclerosis
Koelwyn, G. J., Corr, E. M., Erbay, E., & Moore, K. J. (2018) · Nature Immunology · doi:10.1038/s41590-018-0113-3 · Cited by 555
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., & Ren, J. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07166-8 · Cited by 447
“3) [123].”
BackgroundMetabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
“Desmosterol promotes LXR-mediated cholesterol efflux in peritoneal macrophages via LXR target genes such as ABC transporters, which is linked with attenuation of TLR signaling and decreased inflammatory signatures [233, 235, 236].”
BackgroundDe Nardo, D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2784 · Cited by 462
“HDL promotes the efflux of cholesterol from macrophages and thus, subsequent TLR activation might be inhibited via changes to lipid raft cholesterol content 23, 24 .”
Macrophages and lipid metabolism
Remmerie, A., & Scott, C. L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.020 · Cited by 433
Ouimet, M., Ediriweera, H. N., Gundra, U. M., Sheedy, F. J., Ramkhelawon, B., Hutchison, S. B., Rinehold, K., van Solingen, C., Fullerton, M. D., Cecchini, K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81676 · Cited by 394
“Finally, although previous studies have shown that free cholesterol enrichment of cellular membranes can enhance inflammatory signaling from lipid rafts, particularly TLR signaling and activation of NF-κB (35, 50, 51), we did not observe a role for miR-33 targeting of the cholesterol transporter ABCA1 in macrophage in…”
Macrophage polarization and metabolism in atherosclerosis
Hou, P., Fang, J., Liu, Z., Shi, Y., Agostini, M., Bernassola, F., Bove, P., Candi, E., Rovella, V., Sica, G., et al. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-06206-z · Cited by 350
“Furthermore, enrichment of free cholesterol in foamy macrophage membranes can boost in fl ammatory signaling from lipid rafts, particularly via the activation of the TLR4 and NF-κ B signaling pathways [119, 120].”
BackgroundMacrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis
Bobryshev, Y. V., Ivanova, E. A., Chistiakov, D. A., Nikiforov, N. G., & Orekhov, A. N. (2016) · BioMed Research International · doi:10.1155/2016/9582430 · Cited by 351
“Cholesterol-richmembranemicrodomains facilitate proinflammatory TLR- and NF-κB-mediated signalling [88].”
BackgroundLipid rafts in immune signalling: current progress and future perspective
Varshney, P., Yadav, V., & Saini, N. (2016) · Immunology · doi:10.1111/imm.12617 · Cited by 332
HDL in innate and adaptive immunity
Catapano, A. L., Pirillo, A., Bonacina, F., & Norata, G. D. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu150 · Cited by 299
Nuclear receptors and nonalcoholic fatty liver disease
Cave, M. C., Clair, H. B., Hardesty, J. E., Falkner, K. C., Feng, W., Clark, B. J., Sidey, J., Shi, H., Aqel, B. A., McClain, C. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.002 · Cited by 279
Cholesterol metabolism in the regulation of inflammatory responses
Bauer, R., Brüne, B., & Schmid, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1121819 · Cited by 290
“deficient cells led to enhanced recruitment of TLRs to these membrane domains, thereby increasing the responsiveness to TLR agonists (Yvan-Charvet et al., 2008; Zhu et al., 2010).”
BackgroundIto, A., Hong, C., Rong, X., Zhu, X., Tarling, E. J., Hedde, P. N., Gratton, E., Parks, J., & Tontonoz, P. (2015) · eLife · doi:10.7554/elife.08009 · Cited by 281
“DOI: 10.7554/eLife.08009 14 of 23 Previous studies have reported that Abca1-deficient macrophages contain more cholesterol and TLR4 protein in plasma membrane lipid rafts and that this results in enhanced inflammatory signaling upon LPS treatment (Koseki et al., 2007; Zhu et al., 2008, 2010).”
BackgroundInfluentialSelf-citationFessler, M. B., & Parks, J. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100253 · Cited by 270
“In primary murine macrophages, raft levels of TLR4 and TLR9, as well as cell responsiveness to TLR2, TLR4, TLR7, and TLR9 ligands, are all directly associated with exogenously manipulated raft cholesterol levels (56, 57).”
BackgroundSelf-citationMechanisms That Regulate Macrophage Burden in Atherosclerosis
Randolph, G. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.301174 · Cited by 265
Targeting nuclear receptors for the treatment of fatty liver disease
Tanaka, N., Aoyama, T., Kimura, S., & Gonzalez, F. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.011 · Cited by 212
“Cholesterol levels in the plasma membrane affect the function of Toll-like receptors (TLRs) and higher ABCA1 expression by LXR activation reduces plasma membrane cholesterol contents and sensitivity of TLRs (Zhu et al., 2010).”
BackgroundHDL-mediated mechanisms of protection in cardiovascular disease
Kontush, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu147 · Cited by 186
“Macrophage ABCA1 is pivotal for this effect.(103) Anti-inflammatory effects of HDL in adipocytes are equally mediated by ABCA1 but also by ABCG1 and SR-BI.”
BackgroundCarroll, R. G., Zasłona, Z., Galván-Peña, S., Koppe, E. L., Sévin, D. C., Angiari, S., Triantafilou, M., Triantafilou, K., Modis, L. K., & O’Neill, L. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001921 · Cited by 189
“As CD14 is permanently sequestered in the lipid raft (13, 23), it is likely that the failure of TLR4 translocation to the lipid raft would reduce the signaling in response to LPS stimulation.”
BackgroundXie, Z., Wang, X., Liu, X., Du, H., Sun, C., Shao, X., Tian, J., Gu, X., Wang, H., Tian, J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007442 · Cited by 190
“brane cholesterol and lipid raft content, which promoted a toll-like receptor 4-MyD88–mediated proinflammatory response.(43) Therefore, the VAT exosome–induced Figure 6.”
BackgroundToll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation
Kim, Y.-C., Lee, S. E., Kim, S. K., Jang, H.-D., Hwang, I., Jin, S., Hong, E.-B., Jang, K.-S., & Kim, H.-S. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0344-0 · Cited by 184
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
Bilotta, M. T., Petillo, S., Santoni, A., & Cippitelli, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584303 · Cited by 171
“This inhibits MyD88-dependent TLRs trafficking by selective reduction of free cholesterol content and suppresses macrophage inflammatory responses (66).”
BackgroundRiwanto, M., & Landmesser, U. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r037762 · Cited by 167
Bioactive Egg Components and Inflammation
Andersen, C. J. (2015) · Nutrients · doi:10.3390/nu7095372 · Cited by 173
“These changes corresponded to increased PBMC mRNA expression of ABCA1, which is known to exert direct and indirect anti-inflammatory activity [120,121].”
BackgroundFotakis, P., Kothari, V., Thomas, D. G., Westerterp, M., Molusky, M. M., Altin, E., Abramowicz, S., Wang, N., He, Y., Heinecke, J. W., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313253 · Cited by 148
Role of lipid microdomains in TLR-mediated signalling
Ruysschaert, J., & Lonez, C. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.03.014 · Cited by 166
Lipid rafts as a therapeutic target
Sviridov, D., Mukhamedova, N., & Miller, Y. I. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000658 · Cited by 151
Yin, K., You, Y., Swier, V., Tang, L., Radwan, M. M., Pandya, A. N., & Agrawal, D. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306132 · Cited by 138
“increase of cell membrane cholesterol and lipid raft content, which facilitate toll-like receptor 4-MyD88-mediated proinflammatory response.(48) In this study, we found that 1,25(OH) 2 D 3 markedly induced the expression of ABCA1 and ABCG1 in”
BackgroundNazir, S., Jankowski, V., Bender, G., Zewinger, S., Rye, K.-A., & van der Vorst, E. P. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.006 · Cited by 140
Wei, Y., Zhu, M., Corbalán-Campos, J., Heyll, K., Weber, C., & Schober, A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304723 · Cited by 139
McClean, C. M., & Tobin, D. M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw068 · Cited by 154
“This action results in D ow nloaded from https://academ ic.oup.com /fem spd/article-abstract/74/7/ftw 068/2197856 by guest on 05 M ay 2019 mycobacteria evading MyD88-dependent macrophages that would recognize their cell surface antigens through the action of TLRs.”
BackgroundInfluentialMacrophage activation in human diseases
Schultze, J. L., Schmieder, A., & Goerdt, S. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.07.003 · Cited by 147
Mukhamedova, N., Hoang, A., Dragoljevic, D., Dubrovsky, L., Pushkarsky, T., Low, H., Ditiatkovski, M., Fu, Y., Ohkawa, R., Meikle, P. J., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007907 · Cited by 133
“One consequence of inactivation of ABCA1 and suppression of cholesterol efflux is an increase in the abundance of lipid rafts [23, 24].”
BackgroundNuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis
Yu, X., Zheng, X., & Tang, C. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.03.004 · Cited by 134
Orozco, L. D., Bennett, B. J., Farber, C. R., Ghazalpour, A., Pan, C., Che, N., Wen, P., Qi, H. X., Mutukulu, A., Siemers, N., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.043 · Cited by 129
“Although previous studies have suggested a connection between toll-like receptor signaling and cholesterol efflux pathways (Zhu et al., 2010), our observed trans-eQTL suggests that Abca1 itself is regulated by Tlr4.”
Canfrán‐Duque, A., Rotllán, N., Zhang, X., Andrés‐Blasco, I., Thompson, B. M., Sun, J., Price, N. L., Fernández‐Fuertes, M., Fowler, J. W., Gómez‐Coronado, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059062 · Cited by 132
Zhang, H., Xue, C., Shah, R., Bermingham, K., Hinkle, C. C., Li, W., Rodrigues, A., Tabita-Martinez, J., Millar, J. S., Cuchel, M., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305860 · Cited by 126
Kruit, J. K., Wijesekara, N., Westwell-Roper, C., Vanmierlo, T., de Haan, W., Bhattacharjee, A., Tang, R., Wellington, C. L., LütJohann, D., Johnson, J. D., et al. (2012) · Diabetes · doi:10.2337/db11-1341 · Cited by 117
“Although the precise mechanism is unknown, recent data suggest that macrophages lacking ABCA1 exhibit increased trafficking of TLRs to lipid rafts, which leads to enhanced signaling (23).”
BackgroundLipid metabolism in astrocytic structure and function
Lee, J. A., Hall, B., Allsop, J., Alqarni, R., & Allen, S. P. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.07.017 · Cited by 116
The metabolic characteristics and changes of chondrocytes in vivo and in vitro in osteoarthritis
Adam, M. S., Zhuang, H., Ren, X., Zhang, Y., & Zhou, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1393550 · Cited by 127
Sorci-Thomas, M. G., Owen, J. S., Fulp, B., Bhat, S., Zhu, X., Parks, J. S., Shah, D., Jerome, W. G., Gerelus, M., Zabalawi, M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m026674 · Cited by 115
Self-citationCholesterol metabolism in pathogenesis of osteoarthritis disease
Farnaghi, S., Crawford, R., Xiao, Y., & Prasadam, I. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13061 · Cited by 120
MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis
Schober, A., Nazari-Jahantigh, M., & Weber, C. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.38 · Cited by 121
Cholesterol in platelet biogenesis and activation
Wang, N., & Tall, A. R. (2016) · Blood · doi:10.1182/blood-2016-01-631259 · Cited by 122
“Enhanced signaling of cell surface receptors located in lipid rafts has been reported in various hematopoietic effector cells in response to membrane cholesterol accumulation.(45,46) Thus, plasmamembrane cholesterol accumulation in platelets could potentially alter the membrane structure and affect signaling via surfa…”
BackgroundLipid rafts in glial cells: role in neuroinflammation and pain processing
Miller, Y. I., Navia-Pelaez, J. M., Corr, M., & Yaksh, T. L. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr119000468 · Cited by 112
“knockout of the cholesterol transporters ABCA1 and ABCG1, augments TLR4 dimerization (35, 36).”
BackgroundSphingomyelin and Its Role in Cellular Signaling
Chakraborty, M., & Jiang, X. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_1 · Cited by 121
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
Robinson, G., Pineda‐Torra, I., Ciurtin, C., & Jury, E. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148552 · Cited by 115
“Blocking NF-κB signaling could therefore increase cellular cholesterol efflux and reduce lipid uptake, with both atheroprotective implications through reduced foam cell formation (124) and antiinflammatory benefits via modulation of cell plasma membrane lipid rafts and reduction of Toll-like receptor trafficking and s…”
BackgroundNormalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain
Navia-Pelaez, J. M., Choi, S.-H., dos Santos Aggum Capettini, L., Xia, Y., Gonen, A., Agatisa-Boyle, C., Delay, L., Gonçalves dos Santos, G., Catroli, G. F., Kim, J., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202059 · Cited by 99
“These data suggest that TLR4 receptor dimerization, which is the first step in the activation of a TLR4 inflammatory cascade, occurs in microglial lipid rafts, as is demonstrated in other cell types (Cheng et al., 2012; Zhu et al., 2010).”
Distel, E., Barrett, T. J., Chung, K., Girgis, N. M., Parathath, S., Essau, C. C., Murphy, A. J., Moore, K. J., & Fisher, E. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.304164 · Cited by 105
Xian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 103
“By modulating membrane cholesterol content and lipid raft organization, macrophage ABCA1 regulates trafficking of Toll-like-receptor 4 (TLR4) to lipid rafts ( Zhu et al., 2010 ).”
BackgroundInfluentialSelf-citationFu, Y., Hu, X., Cao, Y., Zhang, Z., & Zhang, N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.407 · Cited by 100
Zamanian-Daryoush, M., & DiDonato, J. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00265 · Cited by 100
“Cholesterol efflux by apoA-I/HDL via ABCA1 and ABCG1 disrupts lipid rafts and their associated signaling pathways (Triantafilou et al., 2002; Zhu et al., 2010).”
BackgroundBuckley, M. L., & Ramji, D. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.011 · Cited by 106
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Pirillo, A., Bonacina, F., Norata, G. D., & Catapano, A. L. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0715-0 · Cited by 101
“reported in macrophages where selective deficiency of ATB-binding cassette transporter A1 (ABCA1) leads to increased MyD88-dependent TLRs recruitment to lipid rafts [11] thus changing macrophage toward an hyper-responsive phenotype to LPS challenge.”
BackgroundCrosstalk between reverse cholesterol transport and innate immunity
Azzam, K. M., & Fessler, M. B. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.02.001 · Cited by 96
“Lipid rafts of ABCA1-deficient macrophages contain increased cholesterol and increased TLR4 and TLR9 after cell exposure to the cognate ligands for these receptors [47, 48].”
Self-citationThe Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
Heinz, L. X., Baumann, C., Köberlin, M. S., Snijder, B., Gawish, R., Shui, G., Sharif, O., Aspalter, I. M., Müller, A. C., Kandasamy, R. K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.006 · Cited by 103
“e SMPDL3B Negatively Regulates Innate Immunity”
BackgroundInfluentialNew Roles of HDL in Inflammation and Hematopoiesis
Zhu, X., & Parks, J. S. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150709 · Cited by 91
Self-citationLinalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation
Ma, J., Xu, H., Wu, J., Qu, C., Sun, F., & Xu, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.09.005 · Cited by 96
Regulation of ABCA1 functions by signaling pathways
Liu, Y., & Tang, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.015 · Cited by 90
“Studies with cultured cells have suggested that the anti-inflammatory activity of ABCA1 is secondary to its ability to modulate the cholesterol content of membrane lipid rafts [38, 77, 78, 81].”
BackgroundLamichhane, S., Ahonen, L. L., Dyrlund, T. S., Kemppainen, E., Siljander, H., Hyöty, H., Ilonen, J., Toppari, J., Veijola, R., Hyötyläinen, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28907-8 · Cited by 103
ABC transporters: human disease and pharmacotherapeutic potential
Moore, J. M., Bell, E. L., Hughes, R. O., & Garfield, A. S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.001 · Cited by 101
Fu, Y., Zhou, E., Wei, Z., Liang, D., Wang, W., Wang, T., Guo, M., Zhang, N., & Yang, Z. (2014) · FEBS Journal · doi:10.1111/febs.12801 · Cited by 91
Anti-atherogenic mechanisms of high density lipoprotein: Effects on myeloid cells
Murphy, A. J., Westerterp, M., Yvan-Charvet, L., & Tall, A. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.003 · Cited by 82
“CD14 is essential for MyD88independent LPS signaling through TLR4 [82].”
InfluentialEffects of dyslipidaemia on monocyte production and function in cardiovascular disease
Rahman, M. S., Murphy, A. J., & Woollard, K. J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.34 · Cited by 92
Cheng, A. M., Handa, P., Tateya, S., Schwartz, J., Tang, C., Mitra, P., Oram, J. F., Chait, A., & Kim, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033917 · Cited by 82
Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.037 · Cited by 84
Lu, L., McCurdy, S., Huang, S., Zhu, X., Peplowska, K., Tiirikainen, M., Boisvert, W. A., & Garmire, L. X. (2016) · Scientific Reports · doi:10.1038/srep37446 · Cited by 87
Self-citationEffects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds
Sun, J., Xu, X., & Jin, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880286 · Cited by 93
A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease
Fessler, M. B. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-136aw · Cited by 84
Self-citationWang, H., Wang, J., Wang, J.-H., Wang, Q., Ma, Q., & Chen, Y.-Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1646-6 · Cited by 80
“NF-jB has been reported to play an important role in the regulation of inflammatory cytokines production [26, 27].”
GPR109A and Vascular Inflammation
Chai, J. T., Digby, J. E., & Choudhury, R. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0325-9 · Cited by 82
“ABCA1 was also shown to be responsible in regulating macrophage responsiveness to TLR agonists by modulation of lipid raft cholesterol and MyD88-dependent TLR mobilization to lipid rafts [57].”
BackgroundTang, C. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.924 · Cited by 80
“However, downregulation of ABCA1 has been observed following exposure to inflammatory stimuli including IL-1β, TNF-α, IFN-γ and LPS, in which the nuclear factor-κB (NF-κB) dependent pathway was reported to be involved (13-16).”
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, C. T., Laham, M. S., & Thatcher, G. R. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.011 · Cited by 76
Metabolic reprogramming & inflammation: Fuelling the host response to pathogens
Gleeson, L. E., & Sheedy, F. J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.007 · Cited by 89
Aye, I. L. M. H., Waddell, B. J., Mark, P. J., & Keelan, J. A. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas001 · Cited by 81
miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages
Nguyen, M.-A., Hoang, H.-D., Rasheed, A., Duchez, A.-C., Wyatt, H., Cottee, M. L., Graber, T. E., Susser, L., Robichaud, S., Berber, İ., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319120 · Cited by 74
Szatmári, T., Kis, D., Bogdándi, E. N., Benedek, A., Bright, S. J., Bowler, D. A., Persa, E., Kis, E., Balogh, A., Nagy, L. N., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00347 · Cited by 78
“However, in bystander animals, the fraction of TLR4-expressing DCs decreased to half of the control level and changes were not influenced by radiation dose.”
BackgroundInfluentialImmunometabolism around the Clock
Carroll, R. G., Timmons, G. A., Cervantes‐Silva, M. P., Kennedy, O. D., & Curtis, A. M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.013 · Cited by 77
Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
Zhou, F., & Sun, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.762828 · Cited by 76
Ma, L., Dong, F., Zaid, M., Kumar, A., & Zha, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413245 · Cited by 68
“Another widely reported observation is that ABCA1 decreases lipid raft content in the plasma membrane (18, 19, 21), independent of apoA-I.”
BackgroundLai, L., Azzam, K. M., Lin, W.-C., Rai, P., Lowe, J. M., Gabor, K. A., Madenspacher, J. H., Aloor, J. J., Parks, J. S., Näär, A. M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.723056 · Cited by 67
“We also found that treatment of macrophages with any of several membrane cholesterol-reducing agents that attenuate raft-dependent signaling, including cholesterol-sequestering (filipin and nystatin) and -extracting (methyl- -cyclodextrin) compounds (12, 13, 26), abolished the enhancement of LPSinduced TNF and IL-6 ob…”
BackgroundSelf-citationGulshan, K., Brubaker, G., Conger, H., Wang, S., Zhang, R., Hazen, S. L., & Smith, J. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.308856 · Cited by 66
MicroRNA regulation of macrophages in human pathologies
Wei, Y., & Schober, A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2254-6 · Cited by 67
Tang, C., Houston, B. A., Storey, C., & LeBoeuf, R. C. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m065797 · Cited by 65
Functional crosstalk between membrane lipids and TLR biology
Köberlin, M. S., Heinz, L. X., & Superti‐Furga, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.01.010 · Cited by 63
“Indeed, TLR4 and 9 showed increased receptor recruitment into lipid rafts in ABCA1-deficient macrophages [41].”
BackgroundMethodStamatikos, A., Dronadula, N., Ng, P., Palmer, D., Knight, E., Wacker, B. K., Tang, C., Kim, F., & Dichek, D. A. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.120 · Cited by 60
Dysfunctional HDL: From Structure-Function-Relationships to Biomarkers
Riwanto, M., Rohrer, L., von Eckardstein, A., & Landmesser, U. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_10 · Cited by 68
“This inhibition was attributed to cholesterol efflux through ABCA1, an ATP-binding transporter (Tang et al. 2009; Zhu et al. 2010).”
BackgroundNovel insights: Dynamic foam cells derived from the macrophage in atherosclerosis
Li, J., Meng, Q., Fu, Y., Yu, X., Ji, T., Chao, Y., Chen, Q., Li, Y., & Bian, H. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30300 · Cited by 61
“It is accepted that ABCA1 and ABCG1 can inhibit in- flammation mediated by TLR through different way (Ito et al., 2015; Yvan‐Charvet et al., 2008; Zhu et al., 2010).”
BackgroundHibino, S., Eto, S., Hangai, S., Endo, K., Ashitani, S., Sugaya, M., Osawa, T., Soga, T., Taniguchi, T., & Yanai, H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305245120 · Cited by 61
“…for which cholesterol is an essential structural component in a variety of cellular signaling (38), our observation suggests that spermidine release by tumors may affect signaling pathways other than TCR signaling in the TIME such as those for IFN-γ receptor (39) and Toll-like receptors (40, 41).”
Lipid rafts: A signalling platform linking lipoprotein metabolism to atherogenesis
Lemaire‐Ewing, S., Lagrost, L., & Néel, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.016 · Cited by 63
Ni, M., Zhang, B., Zhao, J., Feng, Q., Peng, J., Hu, Y., & Zhao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108778 · Cited by 60
Chakraborty, M., Lou, C., Huan, C., Kuo, M., Park, T., Cao, G., & Jiang, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60415 · Cited by 59
“In general, more cholesterol efflux is related to less inflammation (12, 13).”
Sobieh, B. H., EL-Mesallamy, H. O., & Kassem, D. H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15700 · Cited by 63
Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins
Bochem, A. E., van der Valk, F. M., Tolani, S., Stroes, E. S., Westerterp, M., & Tall, A. R. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304959 · Cited by 54
“However, because the increases in inflammatory mediators in our study are secondary to genetic changes in ABCA1, and knockdown of ABCA1 increases inflammatory gene expression, it is reasonable to conclude that excessive plaque inflammation contributes to increased atherosclerotic burden.(14,23) Our findings suggest an…”
Background
Metadata
- Authors
- Zhu, X., Owen, J. S., Wilson, M. D., Li, H., Griffiths, G. L., Thomas, M. J., Hiltbold, E. M., Fessler, M. B., & Parks, J. S.
- Affiliations
- Wake Forest University Health Sciences (US)
- National Institutes of Health (US)
- National Institute of Environmental Health Sciences (US)
- Corresponding author
- Parks, John S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 51
- Issue
- 11
- Pages
- 3196-3206
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC2952560
- OpenAlex
- W2143004078
- Cited by
- 331
- References
- 49
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 16 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 14 · 2019: 21 · 2018: 24 · 2017: 21 · 2016: 28 · 2015: 34 · 2014: 26 · 2013: 26 · 2012: 14
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3638 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Auburn University Scholarly Repository
- Funders
- American Heart Association
- National Institutes of Health (ES102005)
- National Heart, Lung, and Blood Institute (R01HL094525, HL 49373, P01HL049373, HL-094525)
- National Institute of Environmental Health Sciences (Z01ES102005)
- National Center for Complementary and Integrative Health (AT27820)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- ABCA1, macrophages, lipid rafts, free cholesterol, Toll-like receptors, MyD88, TLR4, TLR9, TLR2, TLR7, lipopolysaccharide, CpG, inflammation, cholesterol efflux
- MeSH terms
- Animals, Cholesterol, Inflammation, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Signal Transduction, NF-kappa B, Gene Deletion, ATP-Binding Cassette Transporters, Protein Transport, Membrane Microdomains, Toll-Like Receptors, Toll-Like Receptor 4, Toll-Like Receptor 9, Mice, Myeloid Differentiation Factor 88, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.